Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Feiqiong Gao"'
Autor:
Feiqiong Gao, Qigu Yao, Jiaqi Zhu, Wenyi Chen, Xudong Feng, Bing Feng, Jian Wu, Karel Pacak, Jared Rosenblum, Jiong Yu, Zhengping Zhuang, Hongcui Cao, Lanjuan Li
Publikováno v:
Pharmacological Research, Vol 202, Iss , Pp 107135- (2024)
Externí odkaz:
https://doaj.org/article/b0437a71e28744fb90f180ab576558f6
Autor:
Bing Feng, Xudong Feng, Yingduo Yu, Haoying Xu, Qingqing Ye, Ruitian Hu, Xinru Fang, Feiqiong Gao, Jian Wu, Qiaoling Pan, Jiong Yu, Guanjing Lang, Lanjuan Li, Hongcui Cao
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-16 (2023)
Abstract Background Mesenchymal stem cell (MSC) treatment plays a major role in the management of acute lung injury (ALI), and neutrophils are the initial line of defense against ALI. However, the effect of MSCs on neutrophils in ALI remains mostly u
Externí odkaz:
https://doaj.org/article/45dc2df242f84e8589ae54a6872006ca
Autor:
Wenyi Chen, Feiyan Lin, Xudong Feng, Qigu Yao, Yingduo Yu, Feiqiong Gao, Jiahang Zhou, Qiaoling Pan, Jian Wu, Jinfeng Yang, Jiong Yu, Hongcui Cao, Lanjuan Li
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 19, Iss 1, Pp 100889- (2024)
Primary sclerosing cholangitis (PSC) is an autoimmune cholangiopathy characterized by chronic inflammation of the biliary epithelium and periductal fibrosis, with no curative treatment available, and liver transplantation is inevitable for end-stage
Externí odkaz:
https://doaj.org/article/74f512b028cf4ceeb70b58a5bc9d977d
Autor:
Feiqiong Gao, Qigu Yao, Jiaqi Zhu, Wenyi Chen, Xudong Feng, Bing Feng, Jian Wu, Karel Pacak, Jared Rosenblum, Jiong Yu, Zhengping Zhuang, Hongcui Cao, Lanjuan Li
Publikováno v:
Pharmacological Research, Vol 194, Iss , Pp 106851- (2023)
Hypoxia-inducible factor-2α (HIF-2α) is a transcription factor responsible for regulating genes related to angiogenesis and metabolism. This study aims to explore the effect of a previously unreported mutation c.C2473T (p.R825S) in the C-terminal t
Externí odkaz:
https://doaj.org/article/f6a2ecd5f0b04ba1a930d52bb80e0ca6
Autor:
Qigu Yao, Wenyi Chen, Yingduo Yu, Feiqiong Gao, Jiahang Zhou, Jian Wu, Qiaoling Pan, Jinfeng Yang, Lingling Zhou, Jiong Yu, Hongcui Cao, Lanjuan Li
Publikováno v:
Research, Vol 6 (2023)
Primary sclerosing cholangitis (PSC) is a biliary disease accompanied by chronic inflammation of the liver and biliary stricture. Mesenchymal stem cells (MSCs) are used to treat liver diseases because of their immune regulation and regeneration-promo
Externí odkaz:
https://doaj.org/article/d6332bb6b4d44874a06fe3dd3f63ea9e
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-20 (2021)
Abstract Background We explored whether stem cell therapy was effective for animal models and patients with Crohn’s disease (CD). Methods We searched five online databases. The relative outcomes were analyzed with the aid of GetData Graph Digitizer
Externí odkaz:
https://doaj.org/article/41008f60b6824708ac92d5f0ef11854d
Autor:
Qigu Yao, Wenyi Chen, Feiqiong Gao, Yuchen Wu, Lingling Zhou, Haoying Xu, Jong Yu, Xinli Zhu, Lan Wang, Lanjuan Li, Hongcui Cao
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 847 (2023)
The noninvasive diagnosis of cholangiocarcinoma (CCA) is insufficiently accurate. Therefore, the discovery of new prognostic markers is vital for the understanding of the CCA mechanism and related treatment. The information on CCA patients in The Can
Externí odkaz:
https://doaj.org/article/9f9a48c071964d3b86fcf46cd329e789
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-20 (2021)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background We explored whether stem cell therapy was effective for animal models and patients with Crohn’s disease (CD). Methods We searched five online databases. The relative outcomes were analyzed with the aid of GetData Graph Digitizer 2.26 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83298ffd8946f372080cbb29cc11e873
https://doaj.org/article/41008f60b6824708ac92d5f0ef11854d
https://doaj.org/article/41008f60b6824708ac92d5f0ef11854d
Publikováno v:
Annals of Hematology. 100:529-540
Graft-versus-host disease (GVHD) prophylaxis based on post-transplant cyclophosphamide (PTCy) or antithymocyte globulin (ATG) is widely used in allogeneic hematopoietic stem cell transplantations (allo-HCT). The differential impacts of PTCy and ATG o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1389180df29ec83136d898ddc7a53bc
https://doi.org/10.1007/s00277-021-04399-x
https://doi.org/10.1007/s00277-021-04399-x